Health Care & Life Sciences » Pharmaceuticals | Marinus Pharmaceuticals Inc.

Marinus Pharmaceuticals Inc.

Marinus Pharmaceuticals Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
40.53 M
Public Float
37.51 M
Marinus Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.99
Market Cap
$234.4 M
Shares Outstanding
52.56 M
Public Float
43.98 M

Profile

Address
170 North Radnor Chester Road
Radnor Pennsylvania 19087
United States
Employees -
Website http://www.marinuspharma.com
Updated 07/08/2019
Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the identification and development of neuropsychiatric therapeutics. Its clinical stage drug product candidate, ganaxolone, is a positive allosteric modulator being developed in three different dose forms: intravenous, capsule, and liquid. The company was founded by Geoffrey E.

Financials

View All

Christopher Michael Cashman
Chairman, President & Chief Executive Officer
Scott N. Braunstein
Independent Director